Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
New Strategies for the Treatment of Indolent Non-Hodgkin’s Lymphomas
1
x
$
0.00
Antipsychotic-Induced Laryngeal Dystonia
1
x
$
30.00
Metabolic Syndrome among Patients Taking Atypical Antipsychotics: A Comparative Cross-Sectional Study at Erada and Mental Health Complex in Taif, Saudi Arabia
1
x
$
30.00
Jefferson B. Prince, MD: Citalopram for the Treatment of Adolescent Anxiety Disorders: A Pilot Study
1
x
$
30.00
Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil
1
x
$
0.00
Obsessive-Compulsive Disorder: Implications of the Efficacy of an SSRI, Paroxetine
1
x
$
30.00
Jack M. Gorman, MD: Merging the Cognitive Behavioral and Psychopharmacological Paradigms in Comparative Studies: Controversies, Issues, and Some Solutions
1
x
$
30.00
Enfoque clínico: Violencia y problemas psicosociales en niños guatemaltecos
1
x
$
0.00
Correlation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses
1
x
$
30.00
Duration of Untreated Illness in Obsessive-Compulsive Disorder and its Associated Factors
1
x
$
30.00
Neuropharmacology of Paroxetine
1
x
$
30.00
Association of CYP2D6*4 Polymorphism with the Steady- State Concentration of Haloperidol in Patients with Alcohol-Induced Psychotic Disorders
1
x
$
30.00
Assessment of the Correlation Between Unipolar and Bipolar Depression, Calcium Levels, Thyroid Function, and Inflammatory Markers: A Pilot Cross-Sectional Study
1
x
$
30.00
View Cart
Checkout
Home
Store
“Assessment of the Correlation Between Unipolar and Bipolar Depression, Calcium Levels, Thyroid Function, and Inflammatory Markers: A Pilot Cross-Sectional Study” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Desvenlafaxine and Venlafaxine Exert Minimal In Vitro Inhibition of Human Cytochrome P450 and P-Glycoprotein Activities
$
30.00
Add to cart
Details
Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?
$
30.00
Add to cart
Details
Recent-Onset Schizophrenia and Adolescent Cannabis Use: MRI Evidence for Structural Hyperconnectivity?
$
30.00
Add to cart
Details
Hypomania Induced by Escitalopram: 2 Case Reports
$
30.00
Add to cart
Details
Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
$
30.00
Add to cart
Details
LETTER TO THE EDITOR: GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC PHARMACOTHERAPY
$
0.00
Add to cart
Details
GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC PHARMACOTHERAPY: AUTHOR REPLY
$
0.00
Add to cart
Details
Letter to the Editor: AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER
$
0.00
Add to cart
Details
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
$
30.00
Add to cart
Details
Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice
$
30.00
Add to cart
Details
Addressing Methodological Issues in Studying Antidepressant Onset Efficacy Using Prespecified Sensitivity Analyses
$
30.00
Add to cart
Details
Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy
$
30.00
Add to cart
Details
Continuous Positive Airways Pressure Treatment in a Patient with Sleep Apnea—Hypopnea Syndrome and Coexisting Bipolar Disorder
$
30.00
Add to cart
Details
Cocaine is a Major Risk Factor for Antipsychotic Induced Akathisia, Parkinsonism and Dyskinesia
$
30.00
Add to cart
Details
The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study
$
30.00
Add to cart
Details
A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders
$
30.00
Add to cart
Details
Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example
$
30.00
Add to cart
Details
Psychometric Evaluation of a Patient-Rated Troubling Symptom Scale for Generalized Anxiety Disorder Clinical Trials
$
30.00
Add to cart
Details
Placebo Response in Depression: A Perspective for Clinical Practice
$
30.00
Add to cart
Details
Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia
$
30.00
Add to cart
Details
Previous
1
…
19
20
21
…
44
Next
Page load link
Go to Top
